Zhang Wenbao, Li Jun, You Hong, Zhang Zhuangzhi, Turson Gulinul, Loukas Alex, McManus Donald P
Molecular Parasitology Laboratory, Australian Centre for International and Tropical Health and Nutrition, Queensland Institute of Medical Research and University of Queensland, Brisbane, Queensland, Australia.
Am J Trop Med Hyg. 2003 Jan;68(1):40-3.
The EG95-based vaccine protects sheep from infection with the dog tapeworm Echinococcus granulosus. The EG95 encoding gene is a member of a multigene family, several members of which are expressed in the oncosphere, believed to be the target of immunity induced by the vaccine. E. granulosus exhibits extensive intraspecific (strain) variation, and variability of the eg95 gene in different isolates of E. granulosus may directly impact the effectiveness of the EG95-based vaccine. We analyzed the eg95 gene from E. granulosus collected in Xinjiang, in northwest China, where hydatid disease is hyperendemic. The gene is expressed in oncospheres, protoscoleces, and immature and mature adult worms, and the eg95 gene family was shown to comprise two basic sequence types. Very limited sequence variation was evident in the EG95 protein from oncospheres. This high degree of sequence conservation predicts that the vaccine will continue to be effective in China and elsewhere.
基于EG95的疫苗可保护绵羊免受犬绦虫细粒棘球绦虫的感染。EG95编码基因是一个多基因家族的成员,该家族的几个成员在原头蚴中表达,原头蚴被认为是该疫苗诱导免疫的靶点。细粒棘球绦虫表现出广泛的种内(株)变异,不同细粒棘球绦虫分离株中eg95基因的变异性可能直接影响基于EG95的疫苗的有效性。我们分析了从中国西北部新疆地区收集的细粒棘球绦虫的eg95基因,该地区包虫病高度流行。该基因在原头蚴、原头节以及未成熟和成熟成虫中表达,并且eg95基因家族显示由两种基本序列类型组成。原头蚴的EG95蛋白中序列变异非常有限。这种高度的序列保守性预示着该疫苗在中国和其他地方将继续有效。